Grants and Contributions:
Title:
UKRI Biomanufacturing - 10098388 ADC Biocomputer - Development of Automated and Computerized Antibody Drug Conjugate Biomanufacturing Device
Agreement Number:
1016660
Agreement Value:
$853,470.00
Agreement Date:
Mar 1, 2024 - Mar 1, 2026
Description:
As part of the international consortium project ADC Biocomputer, this project will focus on the development of an advanced, customizable, automated Antibody Drug Conjugate (ADC) biomanufacturing device.
Organization:
National Research Council Canada
Expected Results:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Location:
Burnaby, British Columbia, CA V5A 4N4
Reference Number:
172-2023-2024-Q4-1016660
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
826908816
Recipient Type:
For-profit organization
Recipient's Legal Name:
iProgen Biotech Inc.
Federal Riding Name:
Burnaby North--Seymour
Federal Riding Number:
59002
Program:
Industrial Research Assistance Program – Contributions to Firms
Program Purpose:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Coverage:
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.
NAICS Code:
541710